These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 25819382)
1. IgA NEPHROPATHY IN PATIENTS RECEIVING A RENAL TRANSPLANT. Lemes-Canuto AP; de Sandes-Freitas TV; Medina-Pestana JO; Mastroianni-Kirsztajn G J Ren Care; 2015 Dec; 41(4):222-30. PubMed ID: 25819382 [TBL] [Abstract][Full Text] [Related]
2. Utility of Oxford Classification in Post-Transplant Immunoglobulin A Nephropathy. Agrawal V; Singh A; Kaul A; Verma R; Jain M; Pandey R Transplant Proc; 2017 Dec; 49(10):2274-2279. PubMed ID: 29198660 [TBL] [Abstract][Full Text] [Related]
3. Outcome of 313 Czech Patients With IgA Nephropathy After Renal Transplantation. Maixnerova D; Hruba P; Neprasova M; Bednarova K; Slatinska J; Suchanek M; Kollar M; Novak J; Tesar V; Viklicky O Front Immunol; 2021; 12():726215. PubMed ID: 34659212 [TBL] [Abstract][Full Text] [Related]
4. Favorable outcome of renal transplantation in patients with IgA nephropathy. Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657 [TBL] [Abstract][Full Text] [Related]
5. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation. Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168 [TBL] [Abstract][Full Text] [Related]
6. IgA nephropathy recurs early in the graft when assessed by protocol biopsy. Ortiz F; Gelpi R; Koskinen P; Manonelles A; Räisänen-Sokolowski A; Carrera M; Honkanen E; Grinyó JM; Cruzado JM Nephrol Dial Transplant; 2012 Jun; 27(6):2553-8. PubMed ID: 22167589 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for graft loss in patients with recurrent IGA nephropathy after renal transplantation. Namba Y; Oka K; Moriyama T; Ichimaru N; Kyo M; Kokado Y; Ito T; Imai E; Aozasa K; Okuyama A; Takahara S Transplant Proc; 2004 Jun; 36(5):1314-6. PubMed ID: 15251321 [TBL] [Abstract][Full Text] [Related]
8. Long term outcome of renal allografts in patients with immunoglobulin A nephropathy. Ng YS; Vathsala A; Chew ST; Chiang GS; Woo KT Med J Malaysia; 2007 Jun; 62(2):109-13. PubMed ID: 18705440 [TBL] [Abstract][Full Text] [Related]
9. Predicting Post-Transplant Recurrence of IgA Nephropathy: The Importance of Crescents. Avasare RS; Rosenstiel PE; Zaky ZS; Tsapepas DS; Appel GB; Markowitz GS; Bomback AS; Canetta PA Am J Nephrol; 2017; 45(2):99-106. PubMed ID: 28056461 [TBL] [Abstract][Full Text] [Related]
10. A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy. Temurhan S; Akgul SU; Caliskan Y; Artan AS; Kekik C; Yazici H; Demir E; Caliskan B; Turkmen A; Oguz FS; Sever MS Transplant Proc; 2017 Apr; 49(3):541-545. PubMed ID: 28340830 [TBL] [Abstract][Full Text] [Related]
11. Single-center long-term results of renal transplantation for IgA nephropathy. Bumgardner GL; Amend WC; Ascher NL; Vincenti FG Transplantation; 1998 Apr; 65(8):1053-60. PubMed ID: 9583865 [TBL] [Abstract][Full Text] [Related]
12. IgA Nephropathy After Renal Transplant: Recurrences and De Novo Cases. Cazorla-López JM; Wu J; Villanego-Fernández F; Naranjo-Muñoz J; Vigara-Sánchez LA; García-García-Doncel A; Orellana-Chávez C; Moreno-Salazar A; García-Álvarez T; Mazuecos-Blanca A Transplant Proc; 2020 Mar; 52(2):515-518. PubMed ID: 32037064 [TBL] [Abstract][Full Text] [Related]
13. Early post-transplant serum IgA level is associated with IgA nephropathy recurrence after kidney transplantation. Garnier AS; Duveau A; Demiselle J; Croué A; Subra JF; Sayegh J; Augusto JF PLoS One; 2018; 13(4):e0196101. PubMed ID: 29694420 [TBL] [Abstract][Full Text] [Related]
14. A clinicopathological study of IgA nephropathy in renal transplant recipients: beneficial effect of angiotensin-converting enzyme inhibitor. Oka K; Imai E; Moriyama T; Akagi Y; Ando A; Hori M; Okuyama A; Toki K; Kyo M; Kokado Y; Takahara S Nephrol Dial Transplant; 2000 May; 15(5):689-95. PubMed ID: 10809812 [TBL] [Abstract][Full Text] [Related]
15. IgA nephropathy and kidney transplantation according to the Oxford classification. Vasconcelos AS; Mazzali M; de Sousa MV J Bras Nefrol; 2023; 45(3):350-356. PubMed ID: 36626310 [TBL] [Abstract][Full Text] [Related]
16. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival. Moroni G; Longhi S; Quaglini S; Gallelli B; Banfi G; Montagnino G; Messa P Nephrol Dial Transplant; 2013 May; 28(5):1305-14. PubMed ID: 23229925 [TBL] [Abstract][Full Text] [Related]
17. Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil. Chandrakantan A; Ratanapanichkich P; Said M; Barker CV; Julian BA Nephrol Dial Transplant; 2005 Jun; 20(6):1214-21. PubMed ID: 15797890 [TBL] [Abstract][Full Text] [Related]
18. Renal transplantation in patients with primary immunoglobulin A nephropathy. Choy BY; Chan TM; Lo SK; Lo WK; Lai KN Nephrol Dial Transplant; 2003 Nov; 18(11):2399-404. PubMed ID: 14551373 [TBL] [Abstract][Full Text] [Related]
19. Recurrence of IgA nephropathy and Henoch-Schönlein purpura after kidney transplantation: risk factors and graft survival. Soler MJ; Mir M; Rodriguez E; Orfila A; Munne A; Vázquez S; Lloveras J; Puig JM Transplant Proc; 2005 Nov; 37(9):3705-9. PubMed ID: 16386512 [TBL] [Abstract][Full Text] [Related]
20. The risk of recurrent IgA nephropathy in a steroid-free protocol and other modifying immunosuppression. Von Visger JR; Gunay Y; Andreoni KA; Bhatt UY; Nori US; Pesavento TE; Elkhammas EA; Winters HA; Nadasdy T; Singh N Clin Transplant; 2014 Aug; 28(8):845-54. PubMed ID: 24869763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]